Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2015 1
2016 2
2018 1
2019 3
2020 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Is pharmacotherapy enough for urgent weight loss in severely obese patients?
Gargallo-Vaamonde J, Perdomo CM, de la Higuera M, Frühbeck G, Salvador J. Gargallo-Vaamonde J, et al. Among authors: de la higuera m. Expert Opin Pharmacother. 2019 Mar;20(4):367-371. doi: 10.1080/14656566.2018.1559818. Epub 2018 Dec 21. Expert Opin Pharmacother. 2019. PMID: 30576254 No abstract available.
GLP-1 Limits Adipocyte Inflammation and Its Low Circulating Pre-Operative Concentrations Predict Worse Type 2 Diabetes Remission after Bariatric Surgery in Obese Patients.
Izaguirre M, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Becerril S, Valentí V, Moncada R, Unamuno X, Silva C, de la Higuera M, Salvador J, Monreal I, Frühbeck G, Catalán V. Izaguirre M, et al. Among authors: de la higuera m. J Clin Med. 2019 Apr 9;8(4):479. doi: 10.3390/jcm8040479. J Clin Med. 2019. PMID: 30970605 Free PMC article.
Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study.
Ruiz-de-Adana MS, Dominguez-Lopez ME, Gonzalez-Molero I, Machado A, Martin V, Cardona I, de-la-Higuera M, Tapia MJ, Soriguer F, Anarte MT, Rojo-Martínez G. Ruiz-de-Adana MS, et al. Among authors: de la higuera m. Med Clin (Barc). 2016 Mar 18;146(6):239-46. doi: 10.1016/j.medcli.2015.09.020. Epub 2015 Dec 4. Med Clin (Barc). 2016. PMID: 26656958 Clinical Trial.